The above was mentioned in last weeks update which may not have been picked up by as many when skimming over the document. Hopefully the future will see Oncosil making a difference to a broader group of cancer sufferers.
- "OncoSil has been approached to conduct a percutaneous trial which it intends to support. A percutaneous approach would allow OncoSil to be used more widely in the body with other indications. This is aimed at expanding our user base to include Interventional Radiologists who could administer the OncoSilTM device.OncoSil has been approached to conduct a percutaneous trial which it intends to support."
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.015(1.30%) |
Mkt cap ! $21.46M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.16 | $1.14 | $32.51K | 28.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14293 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 8971 | 2 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |